LRP1B – a prognostic marker in tubo-ovarian high-grade serous carcinoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LRP1B – a prognostic marker in tubo-ovarian high-grade serous carcinoma
Authors
Keywords
-
Journal
HUMAN PATHOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-09-23
DOI
10.1016/j.humpath.2023.09.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High EVI1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma
- (2023) Paul Jank et al. Journal of Ovarian Research
- LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types
- (2021) Landon C Brown et al. Journal for ImmunoTherapy of Cancer
- Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer
- (2021) Sizhe Hu et al. Computational and Mathematical Methods in Medicine
- LRP1B: A Giant Lost in Cancer Translation
- (2021) Catarina Príncipe et al. Pharmaceuticals
- Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
- (2020) Zhaodong Ji et al. Frontiers in Oncology
- Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades
- (2019) Hao Chen et al. Frontiers in Immunology
- FABP4 as a key determinant of metastatic potential of ovarian cancer
- (2018) Kshipra M. Gharpure et al. Nature Communications
- Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells
- (2017) Zhiqiang Wang et al. EXPERIMENTAL CELL RESEARCH
- Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression
- (2017) Zongyuan Yang et al. Molecular Cancer
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Expression of a recombinant full-length LRP1B receptor in human non-small cell lung cancer cells confirms the postulated growth-suppressing function of this large LDL receptor family member
- (2016) Arno G. Beer et al. Oncotarget
- LRP1B deletion is associated with poor outcome for glioblastoma patients
- (2015) E. Tabouret et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer
- (2015) Huanjie Shao et al. Oncotarget
- Expressions of fatty acid synthase and HER2 are correlated with poor prognosis of ovarian cancer
- (2014) Yunlang Cai et al. MEDICAL ONCOLOGY
- Down expression ofLRP1Bpromotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer
- (2013) Shaobin Ni et al. CANCER SCIENCE
- The Wnt/β-catenin pathway in ovarian cancer: A review
- (2013) Rebecca C. Arend et al. GYNECOLOGIC ONCOLOGY
- LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin
- (2012) Prue A. Cowin et al. CANCER RESEARCH
- Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer
- (2012) YU WANG et al. ONCOLOGY REPORTS
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More